|
|
||||||||
1 Academic Rheumatology and 2 Orthopaedic Surgery Units, University of Bristol, Bristol BS2 8HW, United Kingdom; and 3 Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina 27599
We recently found that
estrogen receptor (ER) antagonists prevent high-dose estrogen from
inducing the formation of new cancellous bone within the medullary
cavity of mouse long bones. In the present investigation, we studied
the role of specific ER subtypes in this response by examining whether
this is impaired in female ER
/
mice previously
generated by targeted gene deletion. Vehicle or 17
-estradiol
(E2) (range 4-4,000
µg · kg
1 · day
1) was
administered to intact female ER
/
mice and wild-type
littermates by subcutaneous injection for 28 days. The osteogenic
response was subsequently assessed by histomorphometry performed on
longitudinal and cross sections of the tibia. E2 was found
to cause an equivalent increase in cancellous bone formation in
ER
/
mice and littermate controls, as assessed at the
proximal and distal regions of the proximal tibial metaphysis.
E2 also resulted in a similar increase in endosteal mineral
apposition rate in these two genotypes, as assessed at the tibial
diaphysis. In contrast, cortical area in ER
/
mice
was found to be greater than that in wild types irrespective of
E2 treatment, as was tibial bone mineral density as
measured by dual-energy X-ray absorptiometry, consistent with previous reports of increased cortical bone mass in these animals. We conclude that, although ER
acts as a negative modulator of cortical modeling, this isoform does not appear to contribute to high-dose estrogen's ability to induce new cancellous bone formation in mouse long bones.
osteoblasts; estrogen receptor; histomorphometry
This article has been cited by other articles:
![]() |
F. M. Smith, L. J. Holt, A. S. Garfield, M. Charalambous, F. Koumanov, M. Perry, R. Bazzani, S. A. Sheardown, B. D. Hegarty, R. J. Lyons, et al. Mice with a Disruption of the Imprinted Grb10 Gene Exhibit Altered Body Composition, Glucose Homeostasis, and Insulin Signaling during Postnatal Life Mol. Cell. Biol., August 15, 2007; 27(16): 5871 - 5886. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Parikka, Z. Peng, T. Hentunen, J. Risteli, T. Elo, H K. Vaananen, and P. Harkonen Estrogen responsiveness of bone formation in vitro and altered bone phenotype in aged estrogen receptor-{alpha}-deficient male and female mice Eur. J. Endocrinol., February 1, 2005; 152(2): 301 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Murashov, R. R. Islamov, R. J. McMurray, E. S. Pak, and D. A. Weidner Estrogen increases retrograde labeling of motoneurons: evidence of a nongenomic mechanism Am J Physiol Cell Physiol, August 1, 2004; 287(2): C320 - C326. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vanderschueren, L. Vandenput, S. Boonen, M. K. Lindberg, R. Bouillon, and C. Ohlsson Androgens and Bone Endocr. Rev., June 1, 2004; 25(3): 389 - 425. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |